Clinical Trial Update: Efficacy and Safety of NestaCell® in Huntington's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on NestaCell® for Huntington's disease, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• NestaCell®

Snippet

Sponsor: Azidus Brasil | Conditions: Huntington Disease | Phase 3 | Status: UNKNOWN